Drugs that contain Naloxone Hydrochloride

1. List of Evzio drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(1 year, 11 months from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system
Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery
May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery
Oct, 2028

(5 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system
Nov, 2028

(5 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring
Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output
Nov, 2029

(6 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10143972 KALEO INC Ultrafiltration membrane and a preparation method thereof
May, 2031

(8 years from now)

US8627816 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2032

(9 years from now)

US9517307 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Jul, 2034

(11 years from now)

US10220158 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Mar, 2035

(12 years from now)

Market Authorisation Date: 03 April, 2014

Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone hcl; Use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

2. List of Evzio (autoinjector) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(1 year, 11 months from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system
Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery
May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery
Oct, 2028

(5 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system
Nov, 2028

(5 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring
Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output
Nov, 2029

(6 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10143792 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
May, 2031

(8 years from now)

US8627816 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2032

(9 years from now)

US9517307 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Jul, 2034

(11 years from now)

US10220158 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Mar, 2035

(12 years from now)

Market Authorisation Date: 19 October, 2016

Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone hcl; Use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

3. List of Kloxxado drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10722510 HIKMA Liquid naloxone spray
Aug, 2034

(11 years from now)

US11135155 HIKMA Liquid naloxone spray
Aug, 2034

(11 years from now)

US10973814 HIKMA Liquid naloxone spray
Aug, 2034

(11 years from now)

Market Authorisation Date: 29 April, 2021

Treatment: Use of naloxone for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients

Dosage: SPRAY;NASAL

More Information on Dosage

4. List of Naloxone Hydrochloride (autoinjector) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(1 year, 11 months from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9814838 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10143792 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
May, 2031

(8 years from now)

Market Authorisation Date: 28 February, 2022

Treatment: Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

5. List of Narcan drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10085937 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9480644 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9775838 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9561177 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9707226 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9468747 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9211253 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9629965 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

Market Authorisation Date: 18 November, 2015

Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dosage: SPRAY, METERED;NASAL

How can I launch a generic of NARCAN before it's patent expiration?
More Information on Dosage

6. List of Zimhi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11027072 ADAMIS PHARMS CORP Emergency devices
May, 2039

(16 years from now)

Market Authorisation Date: 15 October, 2021

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic